← SynDRA
TRIAPINE
SynDRA canonical compound SYN0007336 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | RRM1 | RRM2 |
| Mechanism of action | ribonucleotide reductase inhibitor |
All known targets
Mechanisms of action (all sources)
- RRM1 INHIBITOR
- Ribonucleotide reductase inhibitor
- RRM2B INHIBITOR
- RRM2 MODULATOR
Cross-references
Synonyms
- OCX-191
- 3-AP
- NSC-663249
- OCX-0191
- PAN-811
- 3-Apct
- 3-Aminopyridine-2-carboxaldehyde- thiosemicarbazone
- UNII-U4XIL4091C
- NSC 663249
- OCX 191
- 2-((3-Aminopyridin-2-yl)methylene)hydrazinecarbothioamide
- C7H9N5S
- U4XIL4091C
- 3-aminopyridine-2-carbaldehyde-thiosemicarbazone
- [(E)-(3-amino-2-pyridyl)methyleneamino]thiourea
- Hydrazinecarbothioamide, 2-((3-amino-2-pyridinyl)methylene)-
- (E)-2-((3-aminopyridin-2-yl)methylene)hydrazinecarbothioamide
- Pan 811
- [(E)-(3-aminopyridin-2-yl)methylideneamino]thiourea
- Hydrazinecarbothioamide, 2-[(3-amino-2-pyridinyl)methylene]-, (E)-
- PAN811
- 2-[(3-Amino-2-pyridinyl)methylene]hydrazinecarbothioamide
- SCHEMBL29370
- CHEMBL231616
- OCX 191 [WHO-DD]
- DTXSID90893923
- EX-A1926
- ZINC8665373
- BDBM50198892
- MFCD00924747
- NSC759096
- s7470
- AKOS006273720
- CCG-266543
- DB11940
- NSC-759096
- AC-36254
- AS-16679
- HY-10082
Look up TRIAPINE in the interactive SynDRA portal →